GENENTECH INC
8-A12B, 1995-10-20
MEDICINAL CHEMICALS & BOTANICAL PRODUCTS
Previous: PRUDENTIAL GROWTH OPPORTUNITY FUND INC, 485APOS, 1995-10-20
Next: WITTER DEAN DIVIDEND GROWTH SECURITIES INC, N-30D, 1995-10-20



<PAGE>   1

                       SECURITIES AND EXCHANGE COMMISSION
                              WASHINGTON, DC 20549

                                    FORM 8-A

                FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES
                     PURSUANT TO SECTION 12(b) OR (g) OF THE
                         SECURITIES EXCHANGE ACT OF 1934

                                 GENENTECH, INC.
             (Exact Name of Registrant as Specified in its Charter)

          DELAWARE                                        94-2347624
         (State of                                      (IRS Employer
       Incorporation)                                 Identification No.)

460 POINT SAN BRUNO BLVD., SOUTH SAN FRANCISCO, CA          94080
    (Address of principal executive offices)              (Zip Code)

If this Form relates to the registration of a class of debt securities and is
effective upon filing pursuant to General Instruction A(c)(1) please check the
following box. / /
                                                             
If this Form relates to the registration of a class of debt securities and is to
become effective simultaneously with the effectiveness of a concurrent
registration statement under the Securities Act of 1933 pursuant to General
Instruction A(c)(2) please check the following box. / /

Securities to be registered pursuant to Section 12(b) of the Act:

Title of each class                 Name of each exchange on which              
to be so registered                 each class is to be registered 
- -------------------------           -------------------------------
Callable Putable
Common Stock,
par value $.02 per share            New York Stock Exchange


Securities to be registered pursuant to Section 12(g) of the Act:

                                      None
                                (Title of Class)

                                   Page 1 of 3


<PAGE>   2



Item 1.  DESCRIPTION OF REGISTRANT'S SECURITIES TO BE REGISTERED.

         The description of the Registrant's Callable Putable Common Stock, par
         value $.02 per share ("Special Common Stock") set forth under the
         caption "The Charter Amendment -- Description of the Special Common
         Stock" in the Proxy Statement/Prospectus forming a part of Amendment
         No. 2 to the Registration Statement on Form S-4 of the Registrant
         (Registration Statement No. 33-59949) filed on September 18, 1995, is
         hereby incorporated by reference.

Item 2.  EXHIBITS

         1.       Specimen stock certificate for the Callable Putable Common 
                  Stock, par value $.02 per share, of the Registrant.

         2.       Certificate of Incorporation of the Registrant (incorporated
                  by reference to Exhibit 4.1 to Registration Statement on Form
                  S-3 of the Registrant (Registration Statement No. 33-37361)
                  filed on October 18, 1991).

         3.       Form of Article THIRD of the Registrant's Certificate of
                  Incorporation, amending Article THIRD of the Registrant's
                  Certificate of Incorporation included as Exhibit 2 to this
                  Registration Statement (incorporated by reference to Exhibit C
                  to Annex A to the Proxy Statement/Prospectus forming a part of
                  (Pre-Effective) Amendment No. 2 to the Registration Statement 
                  on Form S-4 of the Registrant (Registration Statement No. 
                  33-59949) filed on September 18, 1995).

         4.       By-Laws of the Registrant (incorporated by reference to
                  Exhibit 3.4 to Annual Report on Form 10-K for the year ended
                  December 31, 1990).

         5.       Form of Amended and Restated Governance Agreement, as amended,
                  to be dated as of the effective date of the merger
                  contemplated by the Agreement and Plan of Merger, dated as of
                  May 23, 1995, as amended, among the Registrant, Roche
                  Holdings, Inc. and HLR (U.S.) II, Inc. (incorporated by
                  reference to Exhibit A to Annex A to the Proxy
                  Statement/Prospectus forming a part of (Pre-Effective) 
                  Amendment No. 2 to the Registration Statement on Form S-4 of 
                  the Registrant (Registration Statement No. 33-59949) filed 
                  on September 18, 1995).

                                   Page 2 of 3


<PAGE>   3



                                    SIGNATURE

                 Pursuant to the requirements of Section 12 of the Securities
Exchange Act of 1934, the Registrant has duly caused this registration statement
to be signed on its behalf by the undersigned, thereto duly authorized.

                                            GENENTECH, INC.

Date:  October 20, 1995                     By: /s/ John P. McLaughlin
                                               -------------------------------
                                               John P. McLaughlin
                                               Senior Vice President

                                   Page 3 of 3


<PAGE>   4



                                Index to Exhibits

Exhibit
- -------

1.       Specimen stock certificate for the Callable Putable Common Stock, par
         value $.02 per share, of the Registrant.

2.       Certificate of Incorporation of the Registrant (incorporated by
         reference to Exhibit 4.1 to Registration Statement on Form S-3 of the
         Registrant (Registration Statement No. 33-37361) filed on October 18,
         1991).

3.       Form of Article THIRD of the Registrant's Certificate of Incorporation,
         amending Article THIRD of the Registrant's Certificate of Incorporation
         included as Exhibit 2 to this Registration Statement (incorporated by
         reference to Exhibit C to Annex A to the Proxy Statement/Prospectus
         forming a part of (Pre-Effective) Amendment No. 2 to the Registration 
         Statement on Form S-4 of the Registrant (Registration Statement 
         No. 33-59949) filed on September 18, 1995).

4.       By-Laws of the Registrant (incorporated by reference to Exhibit 3.4 to
         Annual Report on Form 10-K for the year ended December 31, 1990).

5.       Form of Amended and Restated Governance Agreement, as amended, to be
         dated as of the effective date of the merger contemplated by the
         Agreement and Plan of Merger, dated as of May 23, 1995, as amended,
         among the Registrant, Roche Holdings, Inc. and HLR (U.S.) II, Inc.
         (incorporated by reference to Exhibit A to Annex A to the Proxy
         Statement/Prospectus forming a part of (Pre-Effective) Amendment No. 2
         to the Registration Statement on Form S-4 of the Registrant 
         (Registration Statement No. 33-59949) filed on September 18, 1995).



<PAGE>   1


                              CERTIFICATE OF STOCK

                             [GENENTECH, INC LOGO]

             THIS CERTIFICATE IS TRANSFERABLE IN BOSTON OR NEW YORK

 9-27-95 JB                                                            H39751-A
                                                             
   NUMBER                                                           SHARES
               CALLABLE PUTABLE                 CALLABLE PUTABLE 
               COMMON STOCK                     COMMON STOCK     
FBC

[SEAL]

INCORPORATED UNDER THE LAWS                     SEE REVERSE FOR CERTAIN
 OF THE STATE OF DELAWARE                       DEFINITIONS AND A
                                                STATEMENT AS TO THE RIGHTS, 
                                                PREFERENCES, PRIVILEGES AND 
                                                RESTRICTIONS OF A SHARE.

THIS CERTIFIES THAT                             CUSIP 368710 30 7


IS THE RECORD HOLDER OF

   FULLY PAID AND NONASSESSABLE SHARES OF THE CALLABLE PUTABLE COMMON STOCK,
                               $.02 PAR VALUE, OF

Genentech, Inc., transferable on the books of the Corporation by the holder
hereof in person or by duly authorized attorney upon surrender of this
certificate properly endorsed. This certificate is not valid until countersigned
and registered by the Transfer Agent and Registrar.

    Witness the facsimile seal of the Corporation and the facsimile
signatures of its duly authorized officers.

Dated:

COUNTERSIGNED AND REGISTERED:                         
THE FIRST NATIONAL BANK OF BOSTON                     /s/ Robert A. Swanson     
TRANSFER AGENT AND REGISTRAR
BY                                                      CHAIRMAN OF THE BOARD 

AUTHORIZED SIGNATURE                                     
                                    [PICTURE]
/s/ John P. McLaughlin                                /s/ Arthur D. Levinson

                                                                PRESIDENT AND  
SECRETARY                                             CHIEF EXECUTIVE OFFICER


<PAGE>   2

THE SHARES OF CALLABLE PUTABLE COMMON STOCK REPRESENTED HEREBY ARE SUBJECT TO
(i) REDEMPTION AT THE OPTION OF THE CORPORATION DURING THE PERIODS, AT THE
PRICES AND ON THE TERMS AND CONDITIONS SPECIFIED IN THE CORPORATION'S
CERTIFICATE OF INCORPORATION, (ii) AN OPTION ON THE PART OF THE HOLDER, UNDER
CERTAIN CIRCUMSTANCES, TO REQUIRE THE CORPORATION TO REDEEM SUCH SHARES OF
CALLABLE PUTABLE COMMON STOCK, AT THE PRICE AND ON THE TERMS AND CONDITIONS
SPECIFIED IN THE CORPORATION'S CERTIFICATE OF INCORPORATION AND (iii)
CONVERSION INTO COMMON STOCK, PAR VALUE $.02, OF THE CORPORATION ON THE DATE
SPECIFIED, AND UPON THE TERMS AND CONDITIONS SET FORTH IN, SUCH CERTIFICATE OF
INCORPORATION. AFTER REDEMPTION THE SHARES REPRESENTED BY THIS CERTIFICATE SHALL
CEASE TO BE OUTSTANDING FOR ALL PURPOSES AND THE HOLDER HEREOF SHALL BE ENTITLED
TO RECEIVE ONLY THE REDEMPTION PRICE OF SUCH SHARES, WITHOUT INTEREST. AFTER
CONVERSION THIS CERTIFICATE SHALL REPRESENT THE SHARES OF COMMON STOCK INTO
WHICH THE SHARES OF CALLABLE PUTABLE COMMON STOCK REPRESENTED HEREBY SHALL HAVE
BEEN CONVERTED, AND THIS CERTIFICATE MAY BE EXCHANGED FOR A NEW CERTIFICATE
REPRESENTING SUCH SHARES OF COMMON STOCK.


                                GENENTECH, INC.

A STATEMENT OF THE RIGHTS, PREFERENCES, PRIVILEGES AND RESTRICTIONS GRANTED TO
OR IMPOSED UPON THE RESPECTIVE CLASSES OR SERIES OF SHARES OF STOCK OF THE
CORPORATION, AND UPON THE HOLDERS THEREOF AS ESTABLISHED BY THE CERTIFICATE OF
INCORPORATION OR BY ANY CERTIFICATE OF DETERMINATION OF PREFERENCES, AND THE
NUMBER OF SHARES CONSTITUTING EACH SERIES OR CLASS AND THE DESIGNATIONS THEREOF,
MAY BE OBTAINED BY ANY SHAREHOLDER OF THE CORPORATION UPON REQUEST AND WITHOUT
CHARGE FROM THE SECRETARY OF THE CORPORATION AT THE PRINCIPAL OFFICE OF THE
CORPORATION.


     The following abbreviations, when used in the inscription on the face of
this certificate, shall be construed as though they were written out in full
according to applicable laws or regulations:

    TEN COM - as tenants in common

    TEN ENT - as tenants by the entireties

    JT TEN  - as joint tenants with right of survivorship
              and not as tenants in common

    UNIF GIFT MIN. ACT - _________ Custodian __________
                          (Cust)               (Minor)

    under Uniform Gifts to Minors Act ________________
                                           (State)

    Additional abbreviations may also be used though not in the above list.

FOR VALUE RECEIVED, _________ HEREBY SELL, ASSIGN AND TRANSFER UNTO

PLEASE INSERT SOCIAL SECURITY OR OTHER
    IDENTIFYING NUMBER OF ASSIGNEE

______________________________________


________________________________________________________________________________
 (PLEASE PRINT OR TYPEWRITE NAME AND ADDRESS, INCLUDING ZIP CODE, OF ASSIGNEE)

________________________________________________________________________________

________________________________________________________________________________

_________________________________________________________________________ Shares
of the capital stock represented by the within Certificate, and do hereby
irrevocably constitute and appoint

_______________________________________________________________________ Attorney
to transfer the said stock on the books of the within named Corporation with
full power of substitution in the premises.

Dated ________________________________________


                        ________________________________________________________
                        NOTICE: THE SIGNATURE TO THIS ASSIGNMENT MUST CORRESPOND
                                WITH THE NAME AS WRITTEN UPON THE FACE OF THE
                                CERTIFICATE IN EVERY PARTICULAR, WITHOUT
                                ALTERATION OR ENLARGEMENT OR ANY CHANGE
                                WHATEVER.





© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission